152 related articles for article (PubMed ID: 17505990)
1. Can famotidine and omeprazole be combined on a once-daily basis?
Fändriks L; Lönroth H; Pettersson A; Vakil N
Scand J Gastroenterol; 2007 Jun; 42(6):689-94. PubMed ID: 17505990
[TBL] [Abstract][Full Text] [Related]
2. Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
Miner PB; Allgood LD; Grender JM
Aliment Pharmacol Ther; 2007 Jan; 25(1):103-9. PubMed ID: 17229225
[TBL] [Abstract][Full Text] [Related]
3. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.
Abe Y; Inamori M; Togawa J; Kikuchi T; Muramatsu K; Chiguchi G; Kawamura H; Kobayashi N; Kirikoshi H; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
J Gastroenterol; 2004 Jan; 39(1):21-5. PubMed ID: 14767730
[TBL] [Abstract][Full Text] [Related]
4. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine.
Koike T; Ohara S; Sehine H; Kawamura M; Abe Y; Inomata Y; Iijima K; Imatani A; Shimosegawa T
Hepatogastroenterology; 2007 Jun; 54(76):1280-4. PubMed ID: 17629089
[TBL] [Abstract][Full Text] [Related]
5. Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects.
Suzuki T; Yamaguchi T; Odaka T; Kobayashi M; Seza A; Kouzu T; Yokosuka O
Aliment Pharmacol Ther; 2008 Jan; 27(1):66-71. PubMed ID: 17922801
[TBL] [Abstract][Full Text] [Related]
6. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effects of anti-secretory drugs on intragastric acidity: is combined therapy with a proton pump inhibitor and an H2 receptor antagonist effective as initial treatment?
Inamori M; Togawa J; Chiguchi G; Abe Y; Kikuchi T; Muramatsu K; Kawamura H; Kobayashi N; Kirikoshi H; Shimamura T; Sakaguchi T; Takamura T; Ueno N; Nakajima A
J Gastroenterol; 2005 Feb; 40(2):213-4. PubMed ID: 15770408
[No Abstract] [Full Text] [Related]
8. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
Abdul-Hussein M; Freeman J; Castell D
Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic control of premedication with famotidine given on the evening before surgery for the prevention of pneumonitis in heart surgery patients].
Heim J; Müller V; Hummel M; Hetzer R; Adt M
Anaesthesist; 1992 Apr; 41(4):165-70. PubMed ID: 1590572
[TBL] [Abstract][Full Text] [Related]
10. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors.
Tutuian R; Katz PO; Ahmed F; Korn S; Castell DO
Aliment Pharmacol Ther; 2002 Mar; 16(3):473-7. PubMed ID: 11876700
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine.
Adachi K; Komazawa Y; Mihara T; Azumi T; Fujisawa T; Katsube T; Furuta K; Kinoshita Y
J Gastroenterol Hepatol; 2005 Jul; 20(7):1012-5. PubMed ID: 15955208
[TBL] [Abstract][Full Text] [Related]
12. Which has superior acid-suppressive effect, 10 mg omeprazole once daily or 20 mg famotidine twice daily? Effects of single or repeated administration in Japanese Helicobacter pylori-negative CYP2C19 extensive metabolizers.
Shimatani T; Inoue M; Kuroiwa T; Moriwaki M; Xu J; Ikawa K; Morikawa N; Tazuma S
Dig Dis Sci; 2007 Feb; 52(2):390-5. PubMed ID: 17211705
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs.
Tolbert K; Bissett S; King A; Davidson G; Papich M; Peters E; Degernes L
J Vet Intern Med; 2011; 25(1):47-54. PubMed ID: 21143305
[TBL] [Abstract][Full Text] [Related]
14. The effect of once daily omeprazole and succinic acid (VECAM) vs once daily omeprazole on 24-h intragastric pH.
Chowers Y; Atarot T; Pratha VS; Fass R
Neurogastroenterol Motil; 2012 May; 24(5):426-31, e208-9. PubMed ID: 22372795
[TBL] [Abstract][Full Text] [Related]
15. Review article: immediate-release proton-pump inhibitor therapy--potential advantages.
Howden CW
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():25-30. PubMed ID: 16303034
[TBL] [Abstract][Full Text] [Related]
16. Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers.
Hedenström H; Alm C; Kraft M; Grahnén A
Aliment Pharmacol Ther; 1997 Dec; 11(6):1137-41. PubMed ID: 9663842
[TBL] [Abstract][Full Text] [Related]
17. Absence of nocturnal acid breakthrough in Helicobacter pylori-positive subjects treated with twice-daily omeprazole.
Martínek J; Pantoflícková D; Hucl T; Benes M; Dorta G; Lukás M; Spicák J
Eur J Gastroenterol Hepatol; 2004 May; 16(5):445-50. PubMed ID: 15097035
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease.
Furuta K; Adachi K; Komazawa Y; Mihara T; Miki M; Azumi T; Fujisawa T; Katsube T; Kinoshita Y
J Gastroenterol Hepatol; 2006 Oct; 21(10):1581-5. PubMed ID: 16928220
[TBL] [Abstract][Full Text] [Related]
19. [The effect of ranitidine and famotidine on the intragastric pH profile of healthy subjects. Randomized cross-over trial with ranitidine effervescent tablets (300 mg) versus famotidine film tablets (40 mg) ].
Löser C; Burlage M; Fölsch UR
Arzneimittelforschung; 1994 May; 44(5):626-9. PubMed ID: 8024636
[TBL] [Abstract][Full Text] [Related]
20. Intragastric long-term pH-metry in hemodialysis patients. A study with famotidine.
Gladziwa U; Wagner S; Dakshinamurty KV; Bechtel B; Mann H; Sieberth HG
Clin Nephrol; 1991 Aug; 36(2):97-102. PubMed ID: 1934666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]